跳至主要内容
临床试验/JPRN-UMIN000015596
JPRN-UMIN000015596已完成未知

Effects of rivastigmine on the appetite of patients with Alzheimer's disease (Relationship of BuChE activity and ghrelin level in blood) - Effects of rivastigmine on the appetite of patients with Alzheimer's disease (Relationship of BuChE activity and ghrelin level in blood)

Ichihino Memorial Hospital0 个研究点目标入组 20 人开始时间: 2014年11月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fall into one of the following criteria will be excluded from this study: 1) Patients with neurodegenerative disease, schizophrenia, bipolar disorder, or other disease classified in DSM-IV Axis I 2) Patients with DLB, or other systemic disease or neurological disorder (dysthyroidism, vitamin B12 or folic acid deficiency, after head injury, Huntington disease, Parkinson's disease, intradural hematoma, normal pressure hydrocephalus, brain tumor, syphilis, etc.) 3) Patients diagnosed as having VD, or possible VD based on NINDS-AIREN diagnostic criteria 4) Patients with severe cardiovascular disorder 5) Patients with bradycardia (< 50bpm), sick sinus syndrome, or conduction disturbance 6) Patients with acute, severe, or unstable symptoms of asthma 7) Patients showing hypersensitiveness to components of rivastigmine or to carbamate derivative 8) Patients after operation of gastrectomy

研究者

发起方
Ichihino Memorial Hospital

相似试验